IAM
CTKB icon

Innovis Asset Management’s Cytek Biosciences CTKB Stock Holding History

Innovis Asset Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,565
Closed -$149K – 164
2022
Q4 		$149K Buy
+14,565
New +$149K 0.07% 145